Responders and Non-Responders to Treatment of Benign Prostatic Hyperplasia with Transurethral Microwave Thermotherapy

REFERENCES

• Ameye F, Baert L, Pike M, Petrovich Z. Optimization of transurethral hyperthermia: Number of treatments (abstract 152). Proceedings American Urological Association Annual Meeting, May, San Antonio, Texas. J Urol 1993; 149: 251A.
   Google Scholar
• Andersen JT, Nordling J, Walter S. Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings. Scand J Urol Nephrol 1979; 13: 229–236.
   PubMedGoogle Scholar
• Andersen JT. Prostatism. III. Detrusor hyperreflexia and residual urine. Clinical and urodynamic aspects and influence of surgery on the prostate. Scand J Urol Nephrol 1982; 16: 25–30.
   PubMed Web of Science ®Google Scholar
• Baert L, Ameye F, Astrahan M, Petrovich Z. Transurethral microwave hyperthermia for benign prostatic hyperplasia: The Leuven clinical experience. J Endourol 1993; 7: 61–69.
   PubMed Web of Science ®Google Scholar
• Berg C, Choi N, Colombeau P, Debruyne F, Hallin A, Perrin P, et al. Responders versus non-responders to thermotherapy in BPH: A multicenter retrospective analysis of patient and treatment profiles (abstract 149). Proced. American Urological Association Annual Meeting, May, San Antonio, Texas. J Urol 1993; 149: 251A.
   Google Scholar
• Birkhoff JD. Natural history of benign prostatic hypertrophy. In: HinmanJr F, ed. Benign Prostatic Hypertrophy, New York: Springer Verlag, 1983: 5–9.
   Google Scholar
• Chive M. Use of microwave radiometry for hyperthermia monitoring and as a basis for thermal dosimetry methods of hyperthermia control. In: Gautherie M, ed. Series on Clinical Thermology: (subseries of Thermotherapy). Heidelberg: Springer, 1990; 3: 113–128.
   Google Scholar
• Dahlstrand C, Fall M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: Results of a randomized study (abstract 148). Proced. American Urological Annual Meeting, May, San Antonio, Texas. J Urol 1993; 149: 250A.
   PubMedGoogle Scholar
• Debruyne FMJ, Bloem FAG, de la Rosette JJMCH, Laduc R. Transurethral thermotherapy (TUMT) in benign prostatic hyperplasia: Placebo versus TUMT (abstract 146). Proced. American Urological Association Annual Meeting, May, San Antonio, Texas. J Urol 1993; 149, 250A.
   PubMedGoogle Scholar
• Devonec M, Ogden C, Perrin P, St Clair Carter S. Clinical response to transurethral microwave thermotherapy is thermal dose dependent. Eur Urol 1993; 23: 267–274.
   PubMed Web of Science ®Google Scholar
• Devonec M, Tomera K, Perrin P. Review: transurethral microwave thermotherapy in benign prostatic hyperplasia. J Endourol 1993; 7: 255–259.
   PubMed Web of Science ®Google Scholar
• Dorflinger T, Frimodt-Möller PC, Bruskewitz RC, Jensen KME, Iversen P, Madsen P. The significance of uninhibited detrusor contractions in prostatism. J Urol 1985; 133: 819–821.
   PubMed Web of Science ®Google Scholar
• Dreikorn K, Richter R. Conservative non-hormonal treatment of patients with benign prostatic hyperplasia. In: Ackermann R and Schröder FH, eds. Prostatic Hyperplasia. Etiology, Surgical and Conservative Management. Berlin: De Gruyter, 1989: 109–121.
   Google Scholar
• Fujino A, Scardino PT. Transrectal ultrasonography for prostatic cancer. Part II: The response of the prostate to definitive radiotherapy. Cancer 1986; 57: 935–940.
   PubMed Web of Science ®Google Scholar
• Graversen PH, Gasser TC, Wasson JH, Hinman F, Bruskewitz RC. Controversies about indications for transurethral resection of the prostate. J Urol 1989; 141: 475–481.
   PubMed Web of Science ®Google Scholar
• Holtgrewe HL. American Urological Association survey of transurethral prostatectomy and the impact of changing Medicare reimbursement. In: Benign Prostatic Hyperplasia. Urol Clin North Am 1990; 17: 587–593.
   PubMed Web of Science ®Google Scholar
• Homma Y, Aso Y. Transurethral microwave thermotherapy for benign prostatic hyperplasia: A 2-year follow-up study. J Endourol 1993; 7: 261–265.
   PubMed Web of Science ®Google Scholar
• Huskisson EC. Measurement of pain. Lancet 1974; 9: 1127–1131.
   Web of Science ®Google Scholar
• Laduc R, Bloem FAG, Debruyne FMJ. Transurethral microwave thermotherapy in symptomatic benign prostatic hyperplasia. Eur Urol 1993; 23: 275–281.
   PubMed Web of Science ®Google Scholar
• Lepor H. Alphal-adrenergic blockers in the medical management of benign prostatic hyperplasia. Curr Opin Urol 1992; 2: 26–29.
   Google Scholar
• Lindner A, Siegel YI, Korczak D. Serum prostate specific antigen levels during hyperthermia treatment of benign prostatic hyperplasia. J Urol 1990; 144: 1388–1389.
   PubMed Web of Science ®Google Scholar
• Madsen PO, Iversen P. A point system for selecting operative candidates. In: Hinman JRF, editor. Benign Prostatic Hypertrophy. New York: Springer Verlag, 1983: 5–9.
   Google Scholar
• Mebust WK. Increased mortality after transurethral prostatectomy for benign prostatic hyperplasia. Curr Opin Urol 1992; 2: 3–7.
   Google Scholar
• Nissenkorn I, Rotbard M, Slutzker D, Bernheim J. Connection between the length of the heating antenna and volume of the prostate in transurethral thermotherapy for benign prostatic hyperplasia. Eur Urol 1993; 23: 307–311.
   PubMed Web of Science ®Google Scholar
• Nordling J, Ovesen H, Poulsen Al. The intraprostatic spiral-Clinical results in 150 consecutive patients. J Urol 1992; 147: 645–647.
   PubMed Web of Science ®Google Scholar
• Norusis MJ. SPSS—Statistical data analysis. 1990 SPSS Inc. Chicago.
   Google Scholar
• Ogden C, Reddy P, Johnson H, Ramsay J, Carter S. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993; 341: 14–17.
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Ameye F, Pike M, Boyd S, Baert L. Relationship of response to transurethral hyperthermia and prostate volume in BPH patients. Urology 1992; 40: 317–321.
   PubMed Web of Science ®Google Scholar
• Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. New Engl J Med 1989; 320: 1120–1124.
   PubMed Web of Science ®Google Scholar
• Stone NN. Flutamide in treatment of benign prostatic hypertrophy. Urology 1989; 34 (Suppl): 64–68.
   PubMedGoogle Scholar
• Stoner E,The Finasteride study group. The clinical effects of a 5α-reductase inhibitor, finasteride, on benign prostatic hyperplasia. J Urol 1992; 147: 1298–1302.
   PubMed Web of Science ®Google Scholar
• Williams G. Dilatation of the prostatic urethra-Should it have a place in the urologist's armamentarium. Urology 1991; 9: 32–35.
   Web of Science ®Google Scholar
• Yerushalmi A, Fishelovitz Y, Singer D, Reiner I, Arielly J, Abramovici Y, et al. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol 1985; 133: 873–876.
   PubMed Web of Science ®Google Scholar